Modifiable risk factors for cancer in the middle East and North Africa: a scoping review

R Mansour, A Al-Ani, M Al-Hussaini, H Abdel-Razeq… - BMC Public Health, 2024 - Springer
Purpose This scoping review examines controllable predisposing factors attributable to
cancer in the Middle East and North Africa (MENA) region's adult population, highlighting …

The carcinogenicity of opium consumption: a systematic review and meta-analysis

A M. Filho, MC Turner, S Warnakulasuriya… - European Journal of …, 2023 - Springer
The carcinogenicity of opium consumption was recently evaluated by a Working Group
convened by the International Agency for Research on Cancer (IARC). We supplement the …

TERT promoter mutations as simple and non-invasive urinary biomarkers for the detection of urothelial bladder cancer in a high-risk region

H Pakmanesh, O Anvari, N Forey… - International Journal of …, 2022 - mdpi.com
Bladder cancer (BC) is the 10th most common cancer in the world. While there are FDA-
approved urinary assays to detect BC, none have demonstrated sufficient sensitivity and …

Prevalence of tobacco use among cancer patients in Iran: a systematic review and meta-analysis

MM Vakilzadeh, R Khayami, D Daneshdoust… - BMC Public Health, 2024 - Springer
Background The prevalence of tobacco use among various cancer types in Iran remains a
significant concern, necessitating a comprehensive analysis to understand the extent and …

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Tumor Immune Infiltration in Bladder Cancer

GL Liu, H Luo, DD Liang, L Zhong… - Recent Patents on Anti …, 2024 - benthamdirect.com
Background Bladder cancer exhibits substantial heterogeneity encompassing genetic
expressions and histological features. This heterogeneity is predominantly attributed to …

Prevalence of bladder cancer in the Kerman Province, Southeastern Iran, using the complete prevalence method

Z Abdolahinia, M Mirzaee, H Pakmanesh… - … of Occupational Health …, 2022 - johe.rums.ac.ir
Background: Bladder cancer is the 10th most common cancer worldwide. We aimed to
assess the prevalence of bladder cancer in the Kerman Province, in southeast Iran …

[PDF][PDF] Serum and urine apolipoprotien A1 (ApoA1) as biomarkers in bladder cancer.

FH Khalaf, MK Rasheed, MB Ismail - Romanian medical JouRnal, 2024 - researchgate.net
Bladder cancer (BC) is the predominant malignant neoplasm in the urinary system and
ranks as the tenth most prevalent malignant tumor worldwide. Compared with females …

Assessment of Urine and Serum Exosomes as Biomarkers for the Diagnosis of Bladder Cancer

FH Kalaf, MK Rasheed, MB Ismail - Al-Rafidain Journal of Medical Sciences …, 2024 - ajms.iq
Background: Bladder cancer (BC) is the most common malignant tumor in the urinary tract
and the tenth most common malignancy worldwide. Exosomes are 40–100 nm-diameter …

The association between serum level of zinc and copper and prevalence of bladder cancer in Iraq

FH Khalaf, MK Rasheed… - Journal of Wasit for …, 2024 - jwsm.uowasit.edu.iq
Bladder cancer (BC) is the most common malignant tumor in the urinary tract and the tenth
most common malignant tumor throughout the world, with an estimated 4: 1 male-to-female …

[引用][C] Епідеміологія раку сечового міхура: сучасний стан проблеми

С Головко - Здоров'я чоловіка, 2024